Table 4.

Comparison of expansion kinetics of PBMC from HIV-infected and uninfected women.

Stimulus	HIV-infected Median (IQR) N = 5 (× 106)	Uninfected Median (IQR) N = 10 (× 106)	Fold difference	p-value
Anti-CD3 + IL-2	0.42 (0.41–0.46)	1.27 (1.23–1.28)	3.02	< 0.01
Anti-CD3/CD28 + IL-2	0.46 (0.40–0.46)	1.28 (1.22–1.32)	2.78	< 0.01
Anti CD3 + IL-2 + IL-7 + IL-15	0.53 (0.51–0.55)	1.32 (1.28–1.46)	2.49	< 0.01
Dynal beads (3:1) + IL-2	0.59 (0.58–0.59)	1.39 (1.33–1.50)	2.36	< 0.01
Dynal beads(1:5) + IL-2	0.67 (0.64–0.67)	1.44 (1.28–1.58)	2.15	< 0.01
Dynal beads (1:1) + IL-2	0.67 (0.66–0.68)	1.56 (1.22–1.76)	2.33	< 0.01
Dynal beads (1:1) + IL-2+IL-7 + IL-15	0.71 (0.70–0.74)	1.90 (1.83–2.17)	2.68	< 0.01